Search Results - "Guzman, J.C."

CLASSIFICATION OF NOCTURNAL BLOOD PRESSURE PROFILE USING FUZZY SYSTEMS by Melin, P, Prado-Arechiga, G, Miramontes, I, Guzman, J.C

“…OBJECTIVE:Implement a fuzzy inference system for a nocturnal profile classification model, for knowing the nocturnal blood pressure behavior of the patients…”
Get full text

Arterial stiffness characterization in patients with Postural Orthostatic Tachycardia Syndrome and Ehlers-Danlos Syndrome Type 3 by Cheng, J.L, Au, J.S, Choi, H.L, Morillo, C.A, Guzman, J.C, MacDonald, M.J

Get full text

Analyzing the effectiveness and limitations of clinical diagnostic techniques for dengue fever in rural Philippines by Guzman, J.C., Martin, J.A.

Get full text

[PP.15.17] GENETIC OPTIMIZATION OF THE FUZZY RULES IN A NEURO FUZZY HYBRID MODEL FOR BLOOD PRESSURE LEVEL CLASSIFICATION by Melin, P., Guzman, J.C., Prado-Arechiga, G.

Get full text

HYPERTENSION DIAGNOSIS WITH A SOFT COMPUTING MODEL USING A GRAPHICAL USER INTERFACE by Melin, P., Prado-Arechiga, G., Miramontes, I., Guzman, J.C.

Get full text

[PP.08.10] ARTIFICIAL INTELLIGENCE UTILIZING NEURO-FUZZY HYBRID MODEL FOR THE CLASSIFICATION OF BLOOD PRESSURE by Melin, P., Guzman, J.c., Prado-Arechiga, G.

Get full text

A COMPARATIVE STUDY BETWEEN EUROPEAN GUIDELINES AND AMERICAN GUIDELINES USING FUZZY SYSTEMS FOR THE CLASSIFICATION OF BLOOD PRESSURE by Melin, P., Prado-Arechiga, G., Guzman, J.C., Miramontes, I.

Get full text

Correlation between dopamine receptor D2 expression and presence of abnormal involuntary movements in Wistar rats with hemiparkinsonism and dyskinesia by Caro Aponte, P.A., Otálora, C.A., Guzmán, J.C., Turner, L.F., Alcázar, J.P., Mayorga, E.L.

“…Parkinson's disease (PD) is characterised by motor alterations, which are commonly treated with l-DOPA. However, long-term l-DOPA use may cause dyskinesia…”
Get full text

Exact closed forms for the transfer matrix of free oscillations in finite periodic Timoshenko–Ehrenfest beams by Torres-Guzmán, J.C., Díaz-de-Anda, A., Martínez-Argüello, A.M., Arriaga, J.

“…In this work, we obtain closed-form expressions for the transfer matrix of free oscillations in finite periodic Timoshenko–Ehrenfest beams with an arbitrary…”
Get full text

1474P Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study) by Iglesias Gómez, C., Blanco Lorenzo, V., Garcia Dominguez, R., García Carbonero, I., Feliciangeli, E., Galvan Ruiz, S., Gómez de Liaño, A., Perez Valderrama, B., Rodriguez Sanchez, A., Sánchez-Escribano, R., Suarez Rodriguez, C., Lázaro Quintela, M., Gallardo Diaz, E., Guma I Padro, J., Puente, J., Villa Guzman, J.C., García Sanchez, J., Martinez Kareaga, M., Beato Zambrano, M.D.C., Molina-Cerrillo, J.

Get full text

803TiP Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients by Climent Duran, M.A., Basterretxea, L., Sanchez Escribano, R., Llabres, E., Heras Lopez, L., Zambrana, F., Torregrosa, M.D., Girones Sarrio, R., Villa Guzman, J.C., Juan Fita, M.J., Fernandez Nuñez, N.

Get full text

Correlación entre la expresión del receptor dopaminérgico D2 y presencia de movimientos involuntarios anormales (MIA) en un modelo de disquinesia en ratas Wistar hemiparkinsonizadas by Caro Aponte, P.A., Otálora, C.A., Guzmán, J.C., Turner, L.F., Alcázar, J.P., Mayorga, E.L.

“…La enfermedad de Parkinson (EP) se caracteriza por una serie de deficiencias motoras que son tratadas comúnmente con L-DOPA; sin embargo, tras un uso crónico…”
Get full text

Disminución de las discinesias en un modelo de Parkinson en ratas Wistar, mediada por el fitofármaco Mucuna pruriens by J.C. Guzman, C.A. Otalora, P. Caro, E.L. Mayorga, J.P. Alcazar, L.F. Turner

“…Resumen: La enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa cuyo tratamiento sintomático más eficaz es la L-dopa, sin embargo, puede inducir…”
Get full text

P153 Treatment patterns and outcomes in elderly patients with Castration-Resistant Prostate Cancer (mCRPC): A real-world data analysis by Ruiz Vico, M., Montes Albuixech, A., Olmos, D., Miguel Masia, J., Rodriguez Antolin, A., De Velasco Oria, G.A., Herrera Imbroda, B., Llacer Perez, C., Romero Laorden, N., Lozano Mejorada, R., Medina Colmenero, A., Puente Vazquez, J., Morales Barrera, R., Villa Guzman, J.C., Climent, M.A., Fernández Parra, E.M., Rodriguez-Vida, A., Castro, E., Lorente, D.

Get full text

Effect of pH on the optical and structural properties of HfO2:Ln3+, synthesized by hydrothermal route by Montes, E., Martínez-Merlín, I., Guzmán-Olguín, J.C., Guzmán-Mendoza, J., Martín, I.R., García-Hipólito, M., Falcony, C.

“…In this work, the influence of the chlorine ions in the optical and structural properties of hafnium oxide (HfO2) doped with europium (Eu3+) and terbium (Tb3+)…”
Get full text

SPAZO2 (SOGUG): Comparative effectiveness of everolimus (Ev) vs axitinib (Ax) as second-line after first-line pazopanib (1stPz) in metastatic renal carcinoma (mRC) by Arranz Arija, J., Pérez-Valderrama, B., Rodriguez Sanchez, A., Puertas Alvarez, J., Pinto Marin, A., Maximiano Alonso, C., Villa Guzman, J.C., Fernandez Parra, E.M., Gallardo Diaz, E., Gonzalez-Larriba, J., Tafalla García, J., Lambea, J., Constenla Figueiras, M., Mendez Vidal, M.J., Virizuela Echaburu, J.A., Vazquez Mazon, F.J., Etxaniz Ulazia, O., Abad Villar, M.T., Cassinello, J., Jurado García, J.M.

Get full text

Efficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC) by Gajate Borau, P., Martin Marino, A., Gallegos Sancho, I., Villa Guzman, J.C., Velastegui, A., Alonso Gordoa, T., Castellano, D., Rubio Romero, G., Pinto Marin, A., Villalobos Leon, L., Maximiano Alonso, C., Sotelo-Lezama, M.J., Sereno Moyano, M., Rodríguez, J.F., Perezagua Marin, C., Ballesteros, J., Marrupe Gonzalez, D., Rodriguez Lajusticia, L., Tafalla García, J.J., Aguado, C.

Get full text

Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02 by Pérez-Valderrama, B., Font, A., Echaburu, J.A. Virizuela, Hernando, S., Climent, M.A., Arija, J. Arranz, Guzman, J.C. Villa, Llorente, M., Lainez Milagro, N., Mellado, B., González del Alba, A., Gallardo, E., Castellano, D., Anido, U., Domenech, M., Garcia del Muro, X., Puente, J., Morales, R., Bellmunt, J., Garcia-Donas, J.

Get full text

281 small cell bladder cancer analysis from spanish institutions by Fita, M.J. Juan, Ramirez-Backhaus, M., Puntí, X. Bonet, Gomez, J., Ramos, E., Pesquera, L., Rodriguez-Vida, A., Viscasillas, I. Lacasa, Guzman, J.C. Villa, Sanchez-Salas, R., Sanchez, J.L. Sanchez, Miranda, M.J., Valverde, S., Izquierdo, L., Serrano, A., Pellejero, P., Garcia, I., Ortiz, I., Briones, J. Rubio, Climent, M.A.

Get full text

Complex interactions between nicotine and resveratrol in the Drosophila melanogaster wing spot test by Velázquez-Ulloa, N.A., Heres-Pulido, M.E., Santos-Cruz, L.F., Durán-Díaz, A., Castañeda-Partida, L., Browning, A., Carmona-Alvarado, C., Estrada-Guzmán, J.C., Ferderer, G., Garfias, M., Gómez-Loza, B., Magaña-Acosta, M.J., Perry, H.H., Dueñas-García, I.E.

“…Nicotine (NIC) and resveratrol (RES) are chemicals in tobacco and wine, respectively, that are widely consumed concurrently worldwide. NIC is an alkaloid known…”
Get full text